Figure 4.
Analysis of the predictive value of cyclin D1 in patients with MIBC. Disease-free survival of patients with high cyclin D1 expression and lymph node metastasis is compared to that of patients with low cyclin D1 expression and had no lymph node metastasis. Patients were followed-up for 120 months. p=0.421.